Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
Dementia (London, England)|July 16, 2023
The MINDSET Study: Co-Designing Training for Interpreters in Dementia and Cognitive AssessmentsAndrew S Gilbert, Josefine Antoniades, Kerry Hwang, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 1, 2020
Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: Outcomes from the Multicenter OsteoCool Tumor Ablation Post-Market Study (OPuS One Study) in 100 PatientsJason Levy, Thomas Hopkins, Jonathan Morris, et al.
Journal of the American College of Cardiology|September 19, 2003
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trialMitchell J Ross, Howard C Herrmann, David J Moliterno, et al.
Nuclear Medicine and Biology|October 17, 2016
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)David S Geller, Jonathan Morris, Ekaterina Revskaya, et al.
Blood|December 3, 2005
Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapyAnita Hill, Simon H Ridley, Dirk Esser, et al.
Transplantation and Cellular Therapy|December 2, 2022
A Multicenter, Retrospective Study Evaluating Clinical Outcomes of Ruxolitinib Therapy In Heavily Pretreated Chronic GVHD Patients With Steroid FailureJennifer White, Mohamed Elemary, Swe Mar Linn, et al.
Circulation|September 24, 2019
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL TrialMarat Fudim, Jennifer White, Neha J Pagidipati, et al.
Bone Marrow Transplantation|June 26, 2023
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failureIgor Novitzky-Basso, Swe Mar Linn, Jennifer White, et al.
MMWR. Morbidity and Mortality Weekly Report|March 6, 2015
Notes from the field: Adverse events associated with administration of simulation intravenous fluids to patients--United States, 2014Misha P Robyn, Jennifer C Hunter, Amy Burns, et al.
Diagnostic and Prognostic Research|December 16, 2020
Protocol for the development and validation of a risk prediction model for stillbirths from 35 weeks gestation in AustraliaJessica K Sexton, Michael Coory, Sailesh Kumar, et al.
Pageof 27